These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 1491059)

  • 1. Evaluation of the chromatographic procedure for the preparation of a high-purity C1-esterase inhibitor concentrate from cryosupernatant plasma.
    Teh LC; Froger M
    J Chromatogr; 1992 Nov; 582(1-2):65-70. PubMed ID: 1491059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromatographic procedure for preparation of a high-purity C 1 esterase inhibitor concentrate.
    Benny AG; Brimer CM
    J Chromatogr; 1988 Dec; 433():363-6. PubMed ID: 3235568
    [No Abstract]   [Full Text] [Related]  

  • 3. Purification of C1 inhibitor. A new approach for the isolation of this biologically important plasma protease inhibitor.
    Prograis LJ; Hammer CH; Katusha K; Frank MM
    J Immunol Methods; 1987 May; 99(1):113-22. PubMed ID: 3553333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Large-scale preparation of highly purified human C1-inhibitor for therapeutic use.
    Poulle M; Burnouf-Radosevich M; Burnouf T
    Blood Coagul Fibrinolysis; 1994 Aug; 5(4):543-9. PubMed ID: 7841310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A modification of an affinity procedure for purification of human C1- inhibitor that provides a homogeneous stable preparation.
    Donaldson VH; Falconieri MW
    J Immunol Methods; 1993 Jan; 157(1-2):101-4. PubMed ID: 8423351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heat stability of lyophilized C1 inactivator concentrates.
    Wickerhauser M; Williams C; Kolen BL; Busby TF
    Vox Sang; 1987; 53(1):1-6. PubMed ID: 3660764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new simplified procedure for C1 inhibitor purification. A novel use for jacalin-agarose.
    Pilatte Y; Hammer CH; Frank MM; Fries LF
    J Immunol Methods; 1989 Jun; 120(1):37-43. PubMed ID: 2732474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C1 inhibitor: the predominant inhibitor of plasma kallikrein.
    Schapira M; de Agostini A; Colman RW
    Methods Enzymol; 1988; 163():179-85. PubMed ID: 3237074
    [No Abstract]   [Full Text] [Related]  

  • 9. Purification and characterization of human C1-esterase inhibitor.
    Nilsson T; Wiman B
    Biochim Biophys Acta; 1982 Jul; 705(2):271-6. PubMed ID: 6981429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pasteurization of C1 inactivator in the presence of citrate salts.
    Williams C; Wickerhauser M; Busby TF; Ingham KC
    Vox Sang; 1984; 46(5):260-9. PubMed ID: 6730423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [New preparation method of C1 esterase for the dosage of its plasma inhibitor].
    Gozin D; Ollier-Hartmann MP; Lerable J; Hartmann L; Soulier JP
    Biomed Pharmacother; 1983; 37(5):228-30. PubMed ID: 6607074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification of a proteinase inhibitor from bovine serum with C1-inhibitor activity.
    Van Nostrand WE; Cunningham DD
    Biochim Biophys Acta; 1987 Feb; 923(2):167-75. PubMed ID: 3814612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C1 inhibitor: quantification and purification.
    Varga L; Dobó J
    Methods Mol Biol; 2014; 1100():189-205. PubMed ID: 24218261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanofiltered human C1 inhibitor concentrate (Cinryze®): in hereditary angioedema.
    Lyseng-Williamson KA
    BioDrugs; 2011 Oct; 25(5):317-27. PubMed ID: 21942916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factor J, a human inhibitor of complement C1, is a cationic, highly glycosylated protein.
    Jiménez-Clavero MA; González-Rubio C; Fontán G; López-Trascasa M
    Immunol Lett; 1994 Oct; 42(3):185-90. PubMed ID: 7890318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Blood protein technological industrial developments as a mirror of fundamental studies bgy the Institute of Biochemistry of the Ukrainian National Academy of Sciences].
    Volkov GL; Andrianov SI; Horoshnykova TV; Borysevych OS; Gavryliuk OS
    Ukr Biokhim Zh (1999); 2000; 72(4-5):109-21. PubMed ID: 11200439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human C1 inhibitor: improved isolation and preliminary structural characterization.
    Harrison RA
    Biochemistry; 1983 Oct; 22(21):5001-7. PubMed ID: 6416294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of C1 esterase inhibitor by the baculovirus expression vector system: preparation, purification, and characterization.
    Wolff MW; Zhang F; Roberg JJ; Caldwell EE; Kaul PR; Serrahn JN; Murhammer DW; Linhardt RJ; Weiler JM
    Protein Expr Purif; 2001 Aug; 22(3):414-21. PubMed ID: 11483003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C1 dissociation. Spontaneous generation in human serum of a trimer complex containing C1 inactivator, activated C1r, and zymogen C1s.
    Laurell AB; Mårtensson U; Sjöholm AG
    J Immunol; 1987 Dec; 139(12):4145-51. PubMed ID: 2826582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural and circular-dichroism studies on the interaction between human C1-esterase inhibitor and C1s.
    Nilsson T; Sjöholm I; Wiman B
    Biochem J; 1983 Sep; 213(3):617-24. PubMed ID: 6604523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.